Ethical issues in the neurology of aging and cognitive decline

Handbook of Clinical Neurology

Volumn 118, Issue , 2013, Pages 233-242

  Klein, Eran ^a   Karlawish, Jason ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Advance directive; Alzheimer's; Assisted suicide; Biomarkers; Capacity; Dementia; Driving; Ethics; Presymptomatic; Remote monitoring

Indexed keywords

BIOLOGICAL MARKER;

AGING; ALZHEIMER'S; ARTICLE; ASSISTED SUICIDE; CAPACITY; COGNITIVE DEFECT; DEMENTIA; DRIVING; ETHICS; HUMAN; LIVING WILL; NEUROLOGY; PRESYMPTOMATIC; REMOTE SENSING;

ADVANCE DIRECTIVE; ALZHEIMER'S; ASSISTED SUICIDE; BIOMARKERS; CAPACITY; DEMENTIA; DRIVING; ETHICS; PRESYMPTOMATIC; REMOTE MONITORING;

AGING; COGNITION DISORDERS; HUMANS; NEUROLOGY;

EID: 84887127868     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53501-6.00020-2     Document Type: Chapter

References (76)

1. Alzheimer's Association Diagnostic disclosure 2009, Retrieved March 1, 2009, from,. http://www.alz.org/professionals_and_researchers_diagnostic_disclosure.asp.
2. American Psychiatric Association Guidelines for assessing the decision-making capacities of potential research subjects with cognitive impairment. Am J Psychiatry 1998, 155:1649-1650.
3. Appelbaum P.S. Assessment of patients' competence to consent to treatment. N Engl J Med 2007, 357(18):1834-1840. Clinical practice.
4. Bamford C., Lamont S., Eccles M., et al. Disclosing a diagnosis of dementia: a systematic review. Int J Geriatr Psychiatry 2004, 19:151-169.
5. Berghman R. Dementia and end-of-life decisions: Ethical issues - A perspective from The Netherlands. Ethics in Psychiatry: European Contributions 2010, 401-420. Springer, New York. H. Helmchen, N. Sartorius (Eds.).
6. Black B.S., Wechsler M., Fogarty L. Decision making for participation in dementia research. Am J Geriatr Psychiatry 2013, 21:355-363.
7. Brodaty H., Griffin D., Hadzi-Pavlovic D. A survey of dementia carers: doctors' communications, problem behaviours and institutional care. Aust N Z J Psychiatry 1990, 24:362-370.
8. Buchanan A.E., Brock D.W. Deciding for others: The ethics of surrogate decision making 1989, Cambridge University Press, New York.
9. Clafferty R.A., Brown K.W., McCabe E. Under half of psychiatrists tell patients their diagnosis of Alzheimer's disease. Br Med J 1998, 317:603.
10. Congedo M., Causarano R.I., Alberti R., et al. Ethical issues in end of life treatments for patients with dementia. Eur J Neurol 2010, 17:774-779.
11. Day A.M., James I.A., Meyer T.D., et al. Do people with dementia find lies and deception in dementia care acceptable?. Aging Ment Health 2011, 15:822-829.
12. de Boer M.E., Hertogh C.M., Dröes R.M., et al. Advance directives in dementia: Issues of validity and effectiveness. Int Psychogeriatr 2010, 22:201-208.
13. Demiris G., Oliver D.P., Giger J., et al. Older adults' privacy considerations for vision based recognition methods of eldercare applications. Technol Health Care 2009, 17:41-48.
14. Diamond E.L., Jernigan J.A., Moseley R.A., et al. Decision-making ability and advance directive preferences in nursing home patients and proxies. Gerontologist 1989, 29:622-626.
15. Di Nino G., Adversi M., Dekel B.G.S., et al. Peri-operative risk management in patients with Alzheimer's disease. J Alzheimers Dis 2010, 22:121-127.
16. Drazkowski J.F., Sirven J.I. Driving and neurologic disorders. Neurology 2011, 76(Suppl 2):S44-S49.
17. Dresser R. Dworkin on dementia: Elegant theory, questionable policy. Hastings Cent Rep 1995, 25:32-38.
18. Dresser R. Mentally disabled research subjects. The enduring policy issues. JAMA 1996, 276:67-72.
19. Edelstein B. Hopemont Capacity Assessment Interview Manual and Scoring Guide 1999, West Virginia University, Morgantown, WV.
20. Etchells E., Darzins P., Silberfeld M., et al. Assessment of patient capacity to consent to treatment. J Gen Intern Med 1999, 14:27-34.
21. Finucane T.E., Christmas C., Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999, 282:1365-1370.
22. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
23. Garand L., Dew M.A., Lingler J.H., et al. Incidence and predictors of advance care planning among persons with cognitive impairment. Am J Geriatr Psychiatry 2011, 19:712-720.
24. Green R.C., Roberts J.S., Cupples L.A., et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009, 361:245-254.
25. Grisso T., Appelbaum P.S. Assessing competence to consent to treatment: A guide for physicians and other health professionals 1998, Oxford University Press, New York.
26. Grisso T., Appelbaum P. MacArthur Competency Assessment Tool for Treatment (MacCAT-T) 1998, Professional Resource Press, Sarasota, FL.
27. Diagnosis, management and treatment of dementia 1999, American Medical Association, Chicago. R. Guttman, M. Seleski (Eds.).
28. Hawkins A.K., Ho A., Hayden M.R. Lessons from predictive testing for Huntington disease: 25 years on. J Med Genet 2011, 48:649-650.
29. Hertogh C.M., de Boer M.E., Droes R.M., et al. Would we rather lose our life than lose our self? Lessons from the Dutch debate on euthanasia for patients with dementia. Am J Bioeth 2007, 7:48-56.
30. Hoffman S. Beneficial and unusual punishment: an argument in support of prisoner participation in clinical trials. Indiana Law Rev 1999-2000, 33:475-515.
31. Holroyd S., Snustad D.G., Chalifoux Z.L. Attitudes of older adults on being told the diagnosis of Alzheimer's disease. J Am Geriatr Soc 1996, 44:400-403.
32. Holroyd S., Turnbull Q., Wolf A.M. What are patients and their families told about the diagnosis of dementia? Results of a family survey. Int J Geriatr Psychiatry 2002, 17:218-221.
33. Hughes J.C. Views of the person with dementia. J Med Ethics 2001, 27:86-91.
34. Iverson D.J., Gronseth G.S., Reger M.A., et al. Practice parameter update: Evaluation and management of driving risk in dementia report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2010, 74:1316-1324.
35. Jaworska A. Respecting the margins of agency: Alzheimer's patients and the capacity to value. Philos Public Aff 1999, 28:105-138.
36. Jennings L.C. We should give the influenza vaccine to elderly patients in rest homes who are suffering from severe dementia. J Prim Health Care 2011, 3:58-59.
37. Kang H.G., Mahoney D.F., Hoenig H., et al. In situ monitoring of health in older adults: Technologies and issues. J Am Geriatr Soc 2010, 58:1579-1586.
38. Karel M.J., Gurrera R.J., Hicken B., et al. Reasoning in the capacity to make medical decisions: The consideration of values. J Clin Ethics 2010, 21:58-71.
39. Karlawish J. Desktop medicine. JAMA 2010, 304:2061-2062.
40. Karlawish J. Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease. Neurology 2011, 77:1487-1493.
41. Karlawish J.H., Casarett D.J., James B.D. Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial. J Am Geriatr Soc 2002, 50:2019-2024.
42. Kim S.Y.H. The ethics of informed consent in Alzheimer disease research. Nat Rev Neurol 2011, 7:410-414.
43. Kim S.Y.H., Karlawish J.H., Kim H.M., et al. Preservation of the capacity to appoint a proxy decision maker: Implications for dementia research. Arch Gen Psychiatry 2011, 68:214-219.
44. Kopelman L.M. Children as research subjects: A dilemma. J Med Philos 2000, 25:745-764.
45. Laloui K., Wary C., Carlier R.-Y., et al. Making diagnosis of Pompe disease at a presymptomatic stage: To treat or not to treat?. Neurology 2011, 77:594-595.
46. Lampert R., Hayes D. Pacemakers and end-of-life decisions. JAMA 2011, 305:1858-1859.
47. Linnenbringer E., Roberts J.S., Hiraki S., et al. "I know what you told me, but this is what I think": perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genet Med 2010, 12:219-227.
48. Lyerly A.D., Little M.O., Faden R.R. Pregnancy and clinical research. Hastings Cent Rep 2008, 38:53.
49. Lyketsos C.G., Steinberg M., Tschanz J.A.T., et al. Mental and behavioral disturbances in dementia: Findings from the Cache County study on memory in aging. Am J Psychiatry 2000, 157:708-714.
50. Maher A.R., Maglione M., Bagley S., et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. JAMA 2011, 306:1359-1369.
51. Marson D.C., Ingram K.K., Cody H.A., et al. Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. Arch Neurol 1995, 52:949-954.
52. Miles S. A case of death by physical restraint: new lessons from a photograph. J Am Geriatr Soc 1996, 44:291-292.
53. Mitchell S.L., Berkowitz R.E., Lawson F.M. A cross-national survey of tube-feeding decisions in cognitively impaired older persons. J Am Geriatr Soc 2000, 48:391-397.
54. Moye J., Karel M.J., Azar A.R., et al. Capacity to consent to treatment: empirical comparison of three instruments in older adults with and without dementia. Gerontologist 2004, 44:166-175.
55. Orgogozo J.M., Gilman S., Dartigues J.F., et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003, 61:46-54.
56. Phillips L.S., Twombly J.G. It's time to overcome clinical inertia. Ann Intern Med 2008, 148:783-785. [editorial].
57. Phillips L.S., Twombly J.G. Will running the numbers first violate the principles of patient-centered care?. Ann Intern Med 2008, 149:840-841. [reply to letters to the editor].
58. Ponsen M.M., Stoffers D., Wolters E.C., et al. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. J Neurol Neurosurg Psychiatry 2010, 81:396-399.
59. Post S.G., Whitehouse P.J. Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. J Am Geriatr Soc 1995, 43:1423-1429.
60. Raina P., Santaguida P., Ismaila A., et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Intern Med 2008, 148:379-397.
61. Rice K., Warner N. Breaking the bad news: what do psychiatrists tell patients with dementia about their illness?. Int J Geriatr Psychiatry 1994, 9:467-471.
62. Rice K., Warner N., Tye T., et al. Telling the diagnosis to patients with Alzheimer's disease. Geriatricians' and psychiatrists' practice differs. Br Med J 1997, 314:376.
63. Rubright J.P., Sankar P., Casarett D.J., et al. A memory and organizational aid improves Alzheimer disease research consent capacity: Results of a randomized, controlled trial. Am J Geriatr Psychiatry 2010, 18:1124-1132.
64. Sachs G.A., Shega J.W., Cox-Hayley D. Barriers to excellent end-of-life care for patients with dementia. J Gen Intern Med 2004, 19:1057-1063.
65. Schermer M. Nothing but the truth? On truth and deception in dementia care. Bioethics 2007, 21:13-22.
66. Sehgal A., Galbraith A., Chesney M., et al. How strictly do dialysis patients want their advance directives followed?. JAMA 1992, 267:59-63.
67. Shega J.W., Hougham G.W., Stocking C.B., et al. Barriers to limiting the practice of feeding tube placement in advanced dementia. J Palliat Med 2003, 6:885-893.
68. Sperling R.A., Aisen P.S., Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:280-292.
69. Steinbrook R. Physician-assisted death - from Oregon to Washington State. N Engl J Med 2008, 359:2513-2515.
70. Tinetti M.E., Liu W.L., Marottoli R.A., et al. Mechanical restraint use among residents of skilled nursing facilities. Prevalence, patterns, and predictors. JAMA 1991, 265:468-471.
71. Treloar A., Crugel M., Prasanna A., et al. Ethical dilemmas: Should antipsychotics ever be prescribed for people with dementia?. Br J Psychiatry 2010, 197:88-90.
72. Van der steen J.T., Ooms M.E., Van Der Wal G., et al. Pneumonia: The demented patient's best friend? Discomfort after starting or withholding antibiotic treatment. J Am Geriatr Soc 2002, 50:1681-1688.
73. Vassilas C.A., Donaldson J. Telling the truth: what do general practitioners say to patients with dementia or terminal cancer?. Br J Gen Pract 1998, 48:1081-1082.
74. Vellas B., Pesce A., Robert P.H., et al. AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials. Alzheimers Dement 2011, 7:e109-e117.
75. Wendler D., Prasad K. Core safeguards for clinical research with adults who are unable to consent. Ann Intern Med 2001, 135:514-523.
76. Yaffe K., Fox P., Newcomer R., et al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 2002, 287:2090-2097.